Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022 – Results from the German KORA-Age study
The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to...
Uloženo v:
| Vydáno v: | Obesity Research & Clinical Practice Ročník 17; číslo 4; s. 349 - 352 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina japonština |
| Vydáno: |
Elsevier Ltd
01.07.2023
Elsevier BV |
| Témata: | |
| ISSN: | 1871-403X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits.
The KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis.
The overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84–4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23–5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05–3.63]), cognitive impairment (3.03 [CI 1.51–6.06]) and arthritis (2.66 [CI 1.39–5.07]) after adjusting for age, sex and marital status.
Sarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal. |
|---|---|
| AbstractList | The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits.OBJECTIVEThe recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits.The KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis.METHODSThe KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis.The overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84-4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23-5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05-3.63]), cognitive impairment (3.03 [CI 1.51-6.06]) and arthritis (2.66 [CI 1.39-5.07]) after adjusting for age, sex and marital status.RESULTSThe overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84-4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23-5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05-3.63]), cognitive impairment (3.03 [CI 1.51-6.06]) and arthritis (2.66 [CI 1.39-5.07]) after adjusting for age, sex and marital status.Sarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal.CONCLUSIONSarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal. The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits. The KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis. The overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84–4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23–5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05–3.63]), cognitive impairment (3.03 [CI 1.51–6.06]) and arthritis (2.66 [CI 1.39–5.07]) after adjusting for age, sex and marital status. Sarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal. |
| Author | Schluessel, Sabine Huemer, Marie-Theres Drey, Michael Peters, Annette Thorand, Barbara |
| Author_xml | – sequence: 1 givenname: Sabine orcidid: 0000-0002-2485-8859 surname: Schluessel fullname: Schluessel, Sabine email: Sabine.Schluessel@med.uni-muenchen.de organization: Department of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336 Munich, Germany – sequence: 2 givenname: Marie-Theres surname: Huemer fullname: Huemer, Marie-Theres organization: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany – sequence: 3 givenname: Annette surname: Peters fullname: Peters, Annette organization: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany – sequence: 4 givenname: Michael surname: Drey fullname: Drey, Michael organization: Department of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336 Munich, Germany – sequence: 5 givenname: Barbara surname: Thorand fullname: Thorand, Barbara organization: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany |
| BackLink | https://cir.nii.ac.jp/crid/1873679867828052608$$DView record in CiNii |
| BookMark | eNp9kctu1DAUhr0oEm3hBbryggWbBF-S2GE3qoZSUTGoQyV2luOcFA-JPdgO0ohN34E35ElwOqy66OZ483_n8vkMnTjvAKELSkpKaPNuV_pg9iUjjJdEloSwE3RKpaBFRfi3l-gsxh0hdd1W_BT93upg_B6cNdh3EG064Dlad4_Td8Dr7Zf1Z6xdj9er7QYb7yK4OEcck04wgUvYBJsgWI39gPNIhv8-_MG3EOcxRTwEPz02uoIwaYc_bW5XxeoeMj_3h1foxaDHCK__v-fo7sP66-XH4mZzdX25uilMxZpU9J2sOK11y7uO045JAgMB2lPBddVqSqFjnRCsGYQgvKXDQDpaNTWtmAAwhp-jt8e---B_zhCTmmw0MI7agZ-jYrIWsmo5kznKjlETfIwBBrUPdtLhoChRi121U4tdtdhVRKpsN0PyCWRs9mO9S0Hb8Xn0zRF11mZqqfmneCNa2QiZT61ZQ5a13h9jkDX9shCUGXPY6PEHHFTv7XMz_gHVxqNT |
| CitedBy_id | crossref_primary_10_1016_j_ejso_2024_108772 crossref_primary_10_1007_s13679_024_00571_2 crossref_primary_10_3390_jcm13102880 crossref_primary_10_1002_jcsm_13821 crossref_primary_10_1016_j_archger_2024_105557 crossref_primary_10_1016_j_archger_2024_105444 crossref_primary_10_1016_j_clnesp_2024_08_017 crossref_primary_10_1016_j_tjfa_2025_100072 crossref_primary_10_1097_MCO_0000000000001062 crossref_primary_10_3389_fnut_2025_1575580 crossref_primary_10_1001_jamanetworkopen_2024_17115 crossref_primary_10_1186_s12877_025_05897_7 crossref_primary_10_3390_jcm13226685 crossref_primary_10_1002_oby_24157 crossref_primary_10_1111_eci_70059 crossref_primary_10_1111_obr_70005 crossref_primary_10_1016_j_clnesp_2025_05_033 crossref_primary_10_1111_nbu_12725 crossref_primary_10_1186_s12877_024_04952_z crossref_primary_10_1186_s12877_024_04955_w |
| Cites_doi | 10.1007/s00198-017-4027-y 10.1016/j.mad.2022.111728 10.1159/000521241 10.1371/journal.pone.0256702 10.1016/j.nut.2019.05.006 10.1007/s00391-011-0245-7 10.1016/j.clnu.2022.03.017 10.1093/ajcn/72.3.694 10.1016/j.clnu.2021.06.009 10.3390/nu14194205 10.1016/j.jamda.2023.03.008 10.1093/ageing/afy169 10.1046/j.1532-5415.2002.50216.x 10.1007/s12603-018-1088-3 |
| ContentType | Journal Article |
| Copyright | 2023 Copyright © 2023. Published by Elsevier Ltd. |
| Copyright_xml | – notice: 2023 – notice: Copyright © 2023. Published by Elsevier Ltd. |
| DBID | RYH AAYXX CITATION 7X8 |
| DOI | 10.1016/j.orcp.2023.08.002 |
| DatabaseName | CiNii Complete CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EndPage | 352 |
| ExternalDocumentID | 10_1016_j_orcp_2023_08_002 S1871403X23000674 |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 ROL RPZ SDF SDG SEL SES SPCBC SSH SSZ T5K UNMZH Z5R ~G- ~HD RYH 9DU AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c426t-db84315a93bb31b280ef0e1d173a49a11eb2b7726f770391ff0b14651427eecc3 |
| ISICitedReferencesCount | 22 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001078691000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1871-403X |
| IngestDate | Sun Sep 28 06:18:59 EDT 2025 Sat Nov 29 07:00:24 EST 2025 Tue Nov 18 21:49:37 EST 2025 Mon Nov 10 09:17:11 EST 2025 Tue Oct 14 19:31:12 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Prevalence Skeletal muscle mass Handgrip strength Fat mass SMM/W Multimorbidity Sarcopenic obesity Disability Bioelectrical impedance analysis Polypharmacy Aging population BIA SO TICS-m BMI WHO Cognitive impairment |
| Language | English Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c426t-db84315a93bb31b280ef0e1d173a49a11eb2b7726f770391ff0b14651427eecc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2485-8859 0000-0002-4329-8607 |
| PQID | 2857849328 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_2857849328 crossref_primary_10_1016_j_orcp_2023_08_002 crossref_citationtrail_10_1016_j_orcp_2023_08_002 nii_cinii_1873679867828052608 elsevier_clinicalkey_doi_10_1016_j_orcp_2023_08_002 |
| PublicationCentury | 2000 |
| PublicationDate | July-August 2023 2023-07-01 2023-07-00 20230701 |
| PublicationDateYYYYMMDD | 2023-07-01 |
| PublicationDate_xml | – month: 07 year: 2023 text: July-August 2023 |
| PublicationDecade | 2020 |
| PublicationTitle | Obesity Research & Clinical Practice |
| PublicationYear | 2023 |
| Publisher | Elsevier Ltd Elsevier BV |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier BV |
| References | Janssen, Heymsfield, Ross (bib8) 2002; 50 Yoshimura, Wakabayashi, Nagano, Matsumoto, Shimazu, Shiraishi (bib13) 2022; 14 Peters, Döring, Ladwig, Meisinger, Linkohr, Autenrieth (bib7) 2011; 44 Suppl 2 Shimizu, Maeda, Ueshima, Inoue, Murotani, Ohno (bib12) 2022; 208 Morikawa, Lee, Makino, Harada, Katayama, Tomida (bib14) 2023 Tou, Wee, Pang, Lau, Jabbar, Seah (bib17) 2021; 16 Gallagher, Heymsfield, Heo, Jebb, Murgatroyd, Sakamoto (bib9) 2000; 72 Donini, Busetto, Bischoff, Cederholm, Ballesteros-Pomar, Batsis (bib5) 2022; 15 Phillips, Strobl, Vogt, Ladwig, Thorand, Grill (bib6) 2017; 28 Someya, Tamura, Kaga, Sugimoto, Kadowaki, Suzuki (bib16) 2022; 41 Wang, Hai, Liu, Cao, Liu, Liu (bib15) 2019; 23 Gupta, Fonarow, Horwich (bib2) 2015; 31 Anon (bib3) 2000; 894 Wei, Nyunt, Gao, Wee, Ng (bib1) 2019; 66 Statistisches Bundesamt. Statistical yearbook 2010 for the Federal Republic of Germany including “International tables” (German). Wiesbaden: Statistisches Bundesamt (Federal Statistical Office). Gao, Mei, Shang, Hu, Chen, Zhao (bib11) 2021; 40 Cruz-Jentoft, Bahat, Bauer, Boirie, Bruyère, Cederholm (bib4) 2019; 48 10.1016/j.orcp.2023.08.002_bib10 Tou (10.1016/j.orcp.2023.08.002_bib17) 2021; 16 Phillips (10.1016/j.orcp.2023.08.002_bib6) 2017; 28 Yoshimura (10.1016/j.orcp.2023.08.002_bib13) 2022; 14 Anon (10.1016/j.orcp.2023.08.002_bib3) 2000; 894 Janssen (10.1016/j.orcp.2023.08.002_bib8) 2002; 50 Wei (10.1016/j.orcp.2023.08.002_bib1) 2019; 66 Gupta (10.1016/j.orcp.2023.08.002_bib2) 2015; 31 Donini (10.1016/j.orcp.2023.08.002_bib5) 2022; 15 Cruz-Jentoft (10.1016/j.orcp.2023.08.002_bib4) 2019; 48 Gao (10.1016/j.orcp.2023.08.002_bib11) 2021; 40 Wang (10.1016/j.orcp.2023.08.002_bib15) 2019; 23 Someya (10.1016/j.orcp.2023.08.002_bib16) 2022; 41 Morikawa (10.1016/j.orcp.2023.08.002_bib14) 2023 Gallagher (10.1016/j.orcp.2023.08.002_bib9) 2000; 72 Peters (10.1016/j.orcp.2023.08.002_bib7) 2011; 44 Suppl 2 Shimizu (10.1016/j.orcp.2023.08.002_bib12) 2022; 208 |
| References_xml | – volume: 41 start-page: 1046 year: 2022 end-page: 1051 ident: bib16 article-title: Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: the Bunkyo health study publication-title: Clin Nutr – reference: Statistisches Bundesamt. Statistical yearbook 2010 for the Federal Republic of Germany including “International tables” (German). Wiesbaden: Statistisches Bundesamt (Federal Statistical Office). – volume: 40 start-page: 4633 year: 2021 end-page: 4641 ident: bib11 article-title: Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis publication-title: Clin Nutr – volume: 14 year: 2022 ident: bib13 article-title: The applicability of the ESPEN and EASO-defined diagnostic criteria for sarcopenic obesity in Japanese patients after stroke: prevalence and association with outcomes publication-title: Nutrients – volume: 208 year: 2022 ident: bib12 article-title: Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation publication-title: Mech Ageing Dev – volume: 44 Suppl 2 start-page: 41 year: 2011 end-page: 54 ident: bib7 article-title: Multimorbidity and successful aging: the population-based KORA-Age study publication-title: Z Gerontol Geriatr – year: 2023 ident: bib14 article-title: Sarcopenic obesity and risk of disability in community-dwelling Japanese older adults: a 5-year longitudinal study publication-title: J Am Med Dir Assoc – volume: 72 start-page: 694 year: 2000 end-page: 701 ident: bib9 article-title: Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index publication-title: Am J Clin Nutr – volume: 28 start-page: 2069 year: 2017 end-page: 2079 ident: bib6 article-title: Sarcopenia is associated with disability status-results from the KORA-Age study publication-title: Osteoporos Int – volume: 50 start-page: 889 year: 2002 end-page: 896 ident: bib8 article-title: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability publication-title: J Am Geriatr Soc – volume: 48 start-page: 16 year: 2019 end-page: 31 ident: bib4 article-title: Sarcopenia: revised European consensus on definition and diagnosis publication-title: Age Ageing – volume: 66 start-page: 180 year: 2019 end-page: 186 ident: bib1 article-title: Long-term changes in nutritional status are associated with functional and mortality outcomes among community-living older adults publication-title: Nutrition – volume: 894 start-page: 1 year: 2000 end-page: 253 ident: bib3 article-title: Obesity: preventing and managing the global epidemic. Report of a WHO consultation publication-title: World Health Organ Tech Rep Ser – volume: 15 start-page: 321 year: 2022 end-page: 335 ident: bib5 article-title: Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement publication-title: Obes Facts – volume: 23 start-page: 14 year: 2019 end-page: 20 ident: bib15 article-title: Associations between sarcopenic obesity and cognitive impairment in elderly Chinese community-dwelling individuals publication-title: J Nutr Health Aging – volume: 31 start-page: 195 year: 2015 end-page: 202 ident: bib2 article-title: Obesity and the obesity paradox in heart failure publication-title: Can J Cardiol – volume: 16 year: 2021 ident: bib17 article-title: Associations of fat mass and muscle function but not lean mass with cognitive impairment: the Yishun study publication-title: PLoS One – volume: 28 start-page: 2069 issue: 7 year: 2017 ident: 10.1016/j.orcp.2023.08.002_bib6 article-title: Sarcopenia is associated with disability status-results from the KORA-Age study publication-title: Osteoporos Int doi: 10.1007/s00198-017-4027-y – volume: 208 year: 2022 ident: 10.1016/j.orcp.2023.08.002_bib12 article-title: Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation publication-title: Mech Ageing Dev doi: 10.1016/j.mad.2022.111728 – volume: 31 start-page: 195 issue: 2 year: 2015 ident: 10.1016/j.orcp.2023.08.002_bib2 article-title: Obesity and the obesity paradox in heart failure publication-title: Can J Cardiol – volume: 15 start-page: 321 issue: 3 year: 2022 ident: 10.1016/j.orcp.2023.08.002_bib5 article-title: Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement publication-title: Obes Facts doi: 10.1159/000521241 – ident: 10.1016/j.orcp.2023.08.002_bib10 – volume: 16 issue: 8 year: 2021 ident: 10.1016/j.orcp.2023.08.002_bib17 article-title: Associations of fat mass and muscle function but not lean mass with cognitive impairment: the Yishun study publication-title: PLoS One doi: 10.1371/journal.pone.0256702 – volume: 66 start-page: 180 year: 2019 ident: 10.1016/j.orcp.2023.08.002_bib1 article-title: Long-term changes in nutritional status are associated with functional and mortality outcomes among community-living older adults publication-title: Nutrition doi: 10.1016/j.nut.2019.05.006 – volume: 44 Suppl 2 start-page: 41 year: 2011 ident: 10.1016/j.orcp.2023.08.002_bib7 article-title: Multimorbidity and successful aging: the population-based KORA-Age study publication-title: Z Gerontol Geriatr doi: 10.1007/s00391-011-0245-7 – volume: 41 start-page: 1046 issue: 5 year: 2022 ident: 10.1016/j.orcp.2023.08.002_bib16 article-title: Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: the Bunkyo health study publication-title: Clin Nutr doi: 10.1016/j.clnu.2022.03.017 – volume: 72 start-page: 694 issue: 3 year: 2000 ident: 10.1016/j.orcp.2023.08.002_bib9 article-title: Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index publication-title: Am J Clin Nutr doi: 10.1093/ajcn/72.3.694 – volume: 40 start-page: 4633 issue: 7 year: 2021 ident: 10.1016/j.orcp.2023.08.002_bib11 article-title: Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis publication-title: Clin Nutr doi: 10.1016/j.clnu.2021.06.009 – volume: 14 issue: 19 year: 2022 ident: 10.1016/j.orcp.2023.08.002_bib13 article-title: The applicability of the ESPEN and EASO-defined diagnostic criteria for sarcopenic obesity in Japanese patients after stroke: prevalence and association with outcomes publication-title: Nutrients doi: 10.3390/nu14194205 – year: 2023 ident: 10.1016/j.orcp.2023.08.002_bib14 article-title: Sarcopenic obesity and risk of disability in community-dwelling Japanese older adults: a 5-year longitudinal study publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2023.03.008 – volume: 48 start-page: 16 issue: 1 year: 2019 ident: 10.1016/j.orcp.2023.08.002_bib4 article-title: Sarcopenia: revised European consensus on definition and diagnosis publication-title: Age Ageing doi: 10.1093/ageing/afy169 – volume: 50 start-page: 889 issue: 5 year: 2002 ident: 10.1016/j.orcp.2023.08.002_bib8 article-title: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability publication-title: J Am Geriatr Soc doi: 10.1046/j.1532-5415.2002.50216.x – volume: 894 start-page: 1 issue: i–xii year: 2000 ident: 10.1016/j.orcp.2023.08.002_bib3 article-title: Obesity: preventing and managing the global epidemic. Report of a WHO consultation publication-title: World Health Organ Tech Rep Ser – volume: 23 start-page: 14 issue: 1 year: 2019 ident: 10.1016/j.orcp.2023.08.002_bib15 article-title: Associations between sarcopenic obesity and cognitive impairment in elderly Chinese community-dwelling individuals publication-title: J Nutr Health Aging doi: 10.1007/s12603-018-1088-3 |
| SSID | ssj0055943 |
| Score | 2.3910692 |
| Snippet | The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new... |
| SourceID | proquest crossref nii elsevier |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 349 |
| SubjectTerms | Aging population Bioelectrical impedance analysis Cognitive impairment Disability Fat mass Handgrip strength Multimorbidity Polypharmacy Prevalence Sarcopenic obesity Skeletal muscle mass |
| Title | Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022 – Results from the German KORA-Age study |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1871403X23000674 https://cir.nii.ac.jp/crid/1873679867828052608 https://www.proquest.com/docview/2857849328 |
| Volume | 17 |
| WOSCitedRecordID | wos001078691000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 issn: 1871-403X databaseCode: AIEXJ dateStart: 20070101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.sciencedirect.com omitProxy: false ssIdentifier: ssj0055943 providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6lKUJcEL8iQKtF4ma5snedrH2MIFBATStSpNystb2mqSKniuOqEhfegVfiSXgSZvbHjqioAInLKrKyXifzeX52Z-Yj5KUIgjIPRyNfjhIIUESR-VkkpV8MVSFKHrK8DDTZhJhO4_k8Oen1vrtamMulqKr46iq5-K-ihmsgbCyd_QtxtzeFC_AZhA4jiB3GPxL8DH4PcmItcm9luv57Te2Koiazk8lUHxhMxrNjzDmvkeui9nRhkU4MADWC_ZslupEMbK_n8iE47vU3y03d1aS8Rb1eeR-OP4798eftZrXW37W8A57tKXSmkdZWY7oSre406GzZYDPzpdmszrYO_Q8bZYlejjC89wHf6y7_UacZG2JlrDPatNNer82e_HZ5gN3kYLxNiLU7b676pkt1QmUNwR7Ev5pPuNPmYgu10ZZq5qY1qrXy3PTNvWZAzF7G-cFqnWM3U8YPTLJtZy7bJMYZro_LQxSHRj_aIbtMDJO4T3bH7ybz984jgKDNFHq457XFWybP8NeVfucg7VSLxTWHQXtBp_fIXRu-0LGB3X3SU9UDcvvIJmg8JF869FGLPqrRRwEuVKOPAvoooo-26KMt-qhDH12VFNFHf3z9Ri3uKOJO38jgjjrcUY27R-TTm8npq0Pf8nv4OfiFG7_IYnBfhzLhWcbDjMWBKgMVFqHgMkpkGKqMZRD9jUohkMigLIMMDDu4-EwoUD38MelXq0o9IVTIKMxyCOWliiMVyqQIypDJJC6yEIP6AQndn5rmtvk9crAsU5fleJ6iIFIURIrErAEbEK-dc2Fav9z4be5klbrXCMxwCsC6cdYeiBUeCUfAB8dDUfAfGTKNjIJ4QF44gaeg9_EwT1Zq1dQpi8HWRhB9xU__aeVn5E73oj0n_c26UXvkVn65WdTrfbIj5vG-xfFPXRbSDw |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sarcopenic+obesity+using+the+ESPEN+and+EASO+consensus+statement+criteria+of+2022+%E2%80%93+Results+from+the+German+KORA-Age+study&rft.jtitle=Obesity+research+%26+clinical+practice&rft.au=Schluessel%2C+Sabine&rft.au=Huemer%2C+Marie-Theres&rft.au=Peters%2C+Annette&rft.au=Drey%2C+Michael&rft.date=2023-07-01&rft.pub=Elsevier+Ltd&rft.issn=1871-403X&rft.volume=17&rft.issue=4&rft.spage=349&rft.epage=352&rft_id=info:doi/10.1016%2Fj.orcp.2023.08.002&rft.externalDocID=S1871403X23000674 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1871-403X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1871-403X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1871-403X&client=summon |